TYW3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.24265050974282E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.65263375101677E-14 |
Normal-vs-Stage2 |
1.162440E-04 |
Normal-vs-Stage3 |
1.92608999999289E-05 |
Normal-vs-Stage4 |
5.405600E-01 |
Stage1-vs-Stage2 |
8.740800E-01 |
Stage1-vs-Stage3 |
6.048000E-01 |
Stage1-vs-Stage4 |
1.007640E-02 |
Stage2-vs-Stage3 |
6.110000E-01 |
Stage2-vs-Stage4 |
3.524400E-02 |
Stage3-vs-Stage4 |
4.668400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.68953739887456E-12 |
Normal-vs-AfricanAmerican |
7.34845517769145E-12 |
Normal-vs-Asian |
9.205600E-02 |
Caucasian-vs-AfricanAmerican |
6.434400E-01 |
Caucasian-vs-Asian |
9.809200E-01 |
AfricanAmerican-vs-Asian |
8.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.66453525910038E-15 |
Normal-vs-Female |
6.01999999849667E-08 |
Male-vs-Female |
7.725800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.58780000550863E-08 |
Normal-vs-Extreme_Weight |
1.63269398001376E-12 |
Normal-vs-Obese |
1.82949999594229E-08 |
Normal-vs-Extreme_Obese |
4.160900E-03 |
Normal_Weight-vs-Extreme_Weight |
5.307600E-01 |
Normal_Weight-vs-Obese |
6.829400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.464800E-01 |
Extreme_Weight-vs-Obese |
2.444200E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.298200E-01 |
Obese-vs-Extreme_Obese |
9.588400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.409740E-04 |
Normal-vs-Age(41-60Yrs) |
1.71840319751482E-11 |
Normal-vs-Age(61-80Yrs) |
3.54161144855425E-14 |
Normal-vs-Age(81-100Yrs) |
1.30830002387228E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.231000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.242200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.992210E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.295400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.352980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.783400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62636570877339E-12 |
Normal-VS-Type2 PRCC |
2.26309999962204E-07 |
Normal-VS-KIRP CIMP |
4.082900E-03 |
Normal-VS-Unclassified PRCC |
2.29269999985071E-07 |
Type1 PRCC-VS-Type2 PRCC |
2.376800E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.924000E-02 |
Type1 PRCC-VS-Unclassified PRCC |
7.161600E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.074600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.809600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.553220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.35909078330587E-12 |
Normal-vs-N1 |
7.045900E-02 |
Normal-vs-N2 |
3.885600E-01 |
N0-vs-N1 |
1.139110E-03 |
N0-vs-N2 |
1.975750E-01 |
N1-vs-N2 |
7.545200E-01 |
|
|